CH3 BioSystems is a supplier of high-performance molecular tools and services for the discovery of protein methylation pathways in cells and tissues.
CH3 BioSystems has assembled an Advisory Board led by internationally recognized researchers and industry leaders. The Advisory Board works closely with the Directors to provide oversight on a regular basis regarding business strategy, legal issues, organizational development, technology, and regulatory policy.
Applied Sciences Group, Inc.
Vice President of Operations
William E. Grieshober, Jr.
Vice President and Deputy General Counsel
Rich Products Corporation
James C.D. Hengst
President and CEO
Director, Business Development
UB Center for Advanced Biomedical and Bioengineering Technology
New York State Center of Excellence in Bioinformatics & Life Sciences